

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 9.41491598 |
| 2 | regulation of acrosome reaction (GO:0060046) | 8.65714554 |
| 3 | sphingosine metabolic process (GO:0006670) | 8.36571055 |
| 4 | regulation of protein glycosylation (GO:0060049) | 8.22341301 |
| 5 | positive regulation of cAMP-mediated signaling (GO:0043950) | 7.91220735 |
| 6 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 7.68858231 |
| 7 | diol metabolic process (GO:0034311) | 7.65339991 |
| 8 | piRNA metabolic process (GO:0034587) | 7.30844111 |
| 9 | sphingoid metabolic process (GO:0046519) | 7.02293716 |
| 10 | thrombin receptor signaling pathway (GO:0070493) | 6.83580143 |
| 11 | glycerol ether metabolic process (GO:0006662) | 6.69330031 |
| 12 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 6.63645037 |
| 13 | notochord development (GO:0030903) | 6.61720975 |
| 14 | ether metabolic process (GO:0018904) | 6.18253297 |
| 15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.64963055 |
| 16 | cellular response to ammonium ion (GO:0071242) | 5.59780994 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.54376751 |
| 18 | mRNA cleavage (GO:0006379) | 5.53201935 |
| 19 | DNA replication-dependent nucleosome assembly (GO:0006335) | 5.52468619 |
| 20 | DNA replication-dependent nucleosome organization (GO:0034723) | 5.52468619 |
| 21 | signal complex assembly (GO:0007172) | 5.37474917 |
| 22 | regulation of cAMP-mediated signaling (GO:0043949) | 5.19847409 |
| 23 | pyrimidine dimer repair (GO:0006290) | 5.12222010 |
| 24 | negative regulation of glycoprotein metabolic process (GO:1903019) | 4.89343464 |
| 25 | ncRNA catabolic process (GO:0034661) | 4.80102711 |
| 26 | negative regulation of cell-matrix adhesion (GO:0001953) | 4.63868237 |
| 27 | cellular response to alkaloid (GO:0071312) | 4.34123164 |
| 28 | regulation of translational elongation (GO:0006448) | 4.24577603 |
| 29 | regulation of female receptivity (GO:0045924) | 4.24514035 |
| 30 | negative regulation of adenylate cyclase activity (GO:0007194) | 4.15213423 |
| 31 | glomerular visceral epithelial cell development (GO:0072015) | 4.09068743 |
| 32 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 4.04631965 |
| 33 | negative regulation of exocytosis (GO:0045920) | 3.95842230 |
| 34 | negative regulation of cyclase activity (GO:0031280) | 3.95375789 |
| 35 | N-terminal protein amino acid acetylation (GO:0006474) | 3.88764921 |
| 36 | cell-cell junction maintenance (GO:0045217) | 3.87880369 |
| 37 | coenzyme catabolic process (GO:0009109) | 3.86506839 |
| 38 | vitamin catabolic process (GO:0009111) | 3.82796500 |
| 39 | fat-soluble vitamin catabolic process (GO:0042363) | 3.82796500 |
| 40 | negative regulation of lyase activity (GO:0051350) | 3.73164760 |
| 41 | female mating behavior (GO:0060180) | 3.71276367 |
| 42 | DNA synthesis involved in DNA repair (GO:0000731) | 3.68914537 |
| 43 | glomerular epithelial cell development (GO:0072310) | 3.58352897 |
| 44 | cornea development in camera-type eye (GO:0061303) | 3.52831631 |
| 45 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.48324970 |
| 46 | response to morphine (GO:0043278) | 3.46549292 |
| 47 | chemical homeostasis within a tissue (GO:0048875) | 3.40038259 |
| 48 | omega-hydroxylase P450 pathway (GO:0097267) | 3.33152360 |
| 49 | dopamine receptor signaling pathway (GO:0007212) | 3.31633854 |
| 50 | response to isoquinoline alkaloid (GO:0014072) | 3.29853590 |
| 51 | wound healing, spreading of epidermal cells (GO:0035313) | 3.26920647 |
| 52 | positive regulation of cholesterol efflux (GO:0010875) | 3.25275389 |
| 53 | regulation of memory T cell differentiation (GO:0043380) | 3.21377345 |
| 54 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.21215320 |
| 55 | regulation of odontogenesis (GO:0042481) | 3.21083833 |
| 56 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.18298438 |
| 57 | smooth muscle tissue development (GO:0048745) | 3.17972028 |
| 58 | positive regulation of protein complex disassembly (GO:0043243) | 3.08573352 |
| 59 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 3.08373750 |
| 60 | thyroid hormone generation (GO:0006590) | 3.08030265 |
| 61 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.03805087 |
| 62 | surfactant homeostasis (GO:0043129) | 3.00741464 |
| 63 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.99395595 |
| 64 | cell junction maintenance (GO:0034331) | 2.97553388 |
| 65 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.97546938 |
| 66 | positive regulation of icosanoid secretion (GO:0032305) | 2.96922657 |
| 67 | polyol biosynthetic process (GO:0046173) | 2.94848504 |
| 68 | positive regulation of fatty acid transport (GO:2000193) | 2.94459475 |
| 69 | positive regulation of cholesterol transport (GO:0032376) | 2.92839532 |
| 70 | positive regulation of sterol transport (GO:0032373) | 2.92839532 |
| 71 | negative regulation of cAMP biosynthetic process (GO:0030818) | 2.91318662 |
| 72 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.90581512 |
| 73 | neuronal action potential (GO:0019228) | 2.89091224 |
| 74 | left/right axis specification (GO:0070986) | 2.88344336 |
| 75 | membrane depolarization during action potential (GO:0086010) | 2.83873525 |
| 76 | negative regulation of cyclic nucleotide biosynthetic process (GO:0030803) | 2.80312148 |
| 77 | regulation of glycoprotein biosynthetic process (GO:0010559) | 2.79758386 |
| 78 | establishment of skin barrier (GO:0061436) | 2.78089089 |
| 79 | glomerular basement membrane development (GO:0032836) | 2.78038857 |
| 80 | sensory perception of pain (GO:0019233) | 2.76296193 |
| 81 | thyroid hormone metabolic process (GO:0042403) | 2.75840335 |
| 82 | response to caffeine (GO:0031000) | 2.71266783 |
| 83 | spermatid development (GO:0007286) | 2.68439431 |
| 84 | glucose catabolic process (GO:0006007) | 2.66241321 |
| 85 | negative regulation of cell-substrate adhesion (GO:0010812) | 2.64970509 |
| 86 | replication fork processing (GO:0031297) | 2.64256302 |
| 87 | negative regulation of purine nucleotide biosynthetic process (GO:1900372) | 2.64071044 |
| 88 | negative regulation of nucleotide biosynthetic process (GO:0030809) | 2.64071044 |
| 89 | viral mRNA export from host cell nucleus (GO:0046784) | 2.61756049 |
| 90 | gene silencing by RNA (GO:0031047) | 2.60891047 |
| 91 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.57655958 |
| 92 | detection of mechanical stimulus (GO:0050982) | 2.56308672 |
| 93 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 16.1674917 |
| 94 | negative regulation of cAMP-mediated signaling (GO:0043951) | 13.8044537 |
| 95 | opioid receptor signaling pathway (GO:0038003) | 12.2716631 |
| 96 | ether lipid metabolic process (GO:0046485) | 11.5660824 |
| 97 | regulation of translational termination (GO:0006449) | 11.2794098 |
| 98 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 10.9430937 |
| 99 | behavioral response to ethanol (GO:0048149) | 10.9118949 |
| 100 | adult feeding behavior (GO:0008343) | 10.2454967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.52297747 |
| 2 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 4.32015376 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.49926451 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.47318477 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.21702742 |
| 6 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.19369156 |
| 7 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 3.19369156 |
| 8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.00088671 |
| 9 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.88478075 |
| 10 | RXR_22108803_ChIP-Seq_LS180_Human | 2.81110540 |
| 11 | EGR1_19032775_ChIP-ChIP_M12_Human | 2.60602581 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.58067417 |
| 13 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.34530969 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.30293810 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.16467022 |
| 16 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.08519198 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.93887255 |
| 18 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.93558154 |
| 19 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.92350679 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.91551926 |
| 21 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.90463091 |
| 22 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.88155071 |
| 23 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.88155071 |
| 24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.86987586 |
| 25 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.82163628 |
| 26 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.79447774 |
| 27 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.79447774 |
| 28 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.71394212 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.60770350 |
| 30 | TCF4_23295773_ChIP-Seq_U87_Human | 1.57353171 |
| 31 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.54377810 |
| 32 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51052718 |
| 33 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.50442066 |
| 34 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.47352685 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45597815 |
| 36 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.44333157 |
| 37 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.44245122 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.43973314 |
| 39 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.43266055 |
| 40 | STAT3_23295773_ChIP-Seq_U87_Human | 1.41961089 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40152508 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39451096 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.32937804 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30906199 |
| 45 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.29356136 |
| 46 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.29172435 |
| 47 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.28211216 |
| 48 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.28119014 |
| 49 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.27438752 |
| 50 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23965266 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20155808 |
| 52 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19051150 |
| 53 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.19013116 |
| 54 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.16914385 |
| 55 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.14421663 |
| 56 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.13333253 |
| 57 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.13198904 |
| 58 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.12962686 |
| 59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12774367 |
| 60 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12719516 |
| 61 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.12137222 |
| 62 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11583758 |
| 63 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11232946 |
| 64 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10657160 |
| 65 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09269160 |
| 66 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08081302 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07294142 |
| 68 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06310468 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.05760854 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05436905 |
| 71 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03995693 |
| 72 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03262340 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02497886 |
| 74 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.02061880 |
| 75 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00923585 |
| 76 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00835486 |
| 77 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00541478 |
| 78 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00154929 |
| 79 | KDM2B_26808549_Chip-Seq_REH_Human | 1.00068661 |
| 80 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.99120205 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99079605 |
| 82 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.98829398 |
| 83 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98552788 |
| 84 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.98218443 |
| 85 | P300_19829295_ChIP-Seq_ESCs_Human | 0.97840214 |
| 86 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97719271 |
| 87 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.97478289 |
| 88 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97391791 |
| 89 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.94382818 |
| 90 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94123155 |
| 91 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.93634850 |
| 92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93393823 |
| 93 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92696196 |
| 94 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.91494776 |
| 95 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91192305 |
| 96 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90006098 |
| 97 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.89545088 |
| 98 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.88974739 |
| 99 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.88803033 |
| 100 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88481692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 6.93725379 |
| 2 | MP0009780_abnormal_chondrocyte_physiolo | 6.83348546 |
| 3 | MP0002876_abnormal_thyroid_physiology | 5.59070045 |
| 4 | MP0005503_abnormal_tendon_morphology | 4.10722499 |
| 5 | MP0005360_urolithiasis | 4.09063406 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.77718506 |
| 7 | MP0000678_abnormal_parathyroid_gland | 3.64755558 |
| 8 | MP0003941_abnormal_skin_development | 3.53784072 |
| 9 | MP0000681_abnormal_thyroid_gland | 2.59853807 |
| 10 | MP0005397_hematopoietic_system_phenotyp | 2.58807238 |
| 11 | MP0001545_abnormal_hematopoietic_system | 2.58807238 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.55992008 |
| 13 | MP0009764_decreased_sensitivity_to | 2.48841536 |
| 14 | MP0003880_abnormal_central_pattern | 2.48507291 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.43565476 |
| 16 | MP0008057_abnormal_DNA_replication | 2.41572933 |
| 17 | MP0003045_fibrosis | 2.33083632 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.31638201 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.31550205 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.19071038 |
| 21 | MP0006035_abnormal_mitochondrial_morpho | 2.17912284 |
| 22 | MP0001664_abnormal_digestion | 2.16318839 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.13184739 |
| 24 | MP0005551_abnormal_eye_electrophysiolog | 1.94536387 |
| 25 | MP0002796_impaired_skin_barrier | 1.89568721 |
| 26 | MP0002249_abnormal_larynx_morphology | 1.88033765 |
| 27 | MP0000015_abnormal_ear_pigmentation | 1.73943804 |
| 28 | MP0005645_abnormal_hypothalamus_physiol | 1.61268384 |
| 29 | MP0003950_abnormal_plasma_membrane | 1.61169762 |
| 30 | MP0003633_abnormal_nervous_system | 1.60825417 |
| 31 | MP0003879_abnormal_hair_cell | 1.58359289 |
| 32 | MP0004858_abnormal_nervous_system | 1.54319949 |
| 33 | MP0003638_abnormal_response/metabolism_ | 1.49099566 |
| 34 | MP0003959_abnormal_lean_body | 1.41391816 |
| 35 | MP0002733_abnormal_thermal_nociception | 1.37023674 |
| 36 | MP0003195_calcinosis | 1.34318782 |
| 37 | MP0001881_abnormal_mammary_gland | 1.32793755 |
| 38 | MP0004782_abnormal_surfactant_physiolog | 1.31688688 |
| 39 | MP0003646_muscle_fatigue | 1.27687295 |
| 40 | MP0002971_abnormal_brown_adipose | 1.20546846 |
| 41 | MP0009046_muscle_twitch | 1.19749915 |
| 42 | MP0003567_abnormal_fetal_cardiomyocyte | 1.14415523 |
| 43 | MP0009745_abnormal_behavioral_response | 1.09358885 |
| 44 | MP0005501_abnormal_skin_physiology | 1.06415435 |
| 45 | MP0000372_irregular_coat_pigmentation | 0.97478478 |
| 46 | MP0002168_other_aberrant_phenotype | 0.94723765 |
| 47 | MP0002272_abnormal_nervous_system | 0.93453956 |
| 48 | MP0000749_muscle_degeneration | 0.93133260 |
| 49 | MP0009765_abnormal_xenobiotic_induced | 0.92753829 |
| 50 | MP0001270_distended_abdomen | 0.90808568 |
| 51 | MP0001324_abnormal_eye_pigmentation | 0.87351104 |
| 52 | MP0010771_integument_phenotype | 0.86495570 |
| 53 | MP0000230_abnormal_systemic_arterial | 0.86297564 |
| 54 | MP0003631_nervous_system_phenotype | 0.82486579 |
| 55 | MP0002108_abnormal_muscle_morphology | 0.79130009 |
| 56 | MP0008775_abnormal_heart_ventricle | 0.78236804 |
| 57 | MP0003937_abnormal_limbs/digits/tail_de | 0.77029504 |
| 58 | MP0002693_abnormal_pancreas_physiology | 0.76619776 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 0.76222718 |
| 60 | MP0005334_abnormal_fat_pad | 0.75769185 |
| 61 | MP0009384_cardiac_valve_regurgitation | 0.75172398 |
| 62 | MP0008874_decreased_physiological_sensi | 0.74579374 |
| 63 | MP0004264_abnormal_extraembryonic_tissu | 0.74067489 |
| 64 | MP0005670_abnormal_white_adipose | 0.73893850 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 0.73673718 |
| 66 | MP0001970_abnormal_pain_threshold | 0.73572514 |
| 67 | MP0000358_abnormal_cell_content/ | 0.73035784 |
| 68 | MP0005310_abnormal_salivary_gland | 0.70531174 |
| 69 | MP0004147_increased_porphyrin_level | 0.70177809 |
| 70 | MP0000569_abnormal_digit_pigmentation | 0.67010150 |
| 71 | MP0001486_abnormal_startle_reflex | 0.66114028 |
| 72 | MP0005195_abnormal_posterior_eye | 0.64190474 |
| 73 | MP0003868_abnormal_feces_composition | 0.63521410 |
| 74 | MP0009672_abnormal_birth_weight | 0.62516751 |
| 75 | MP0002229_neurodegeneration | 0.61905741 |
| 76 | MP0000049_abnormal_middle_ear | 0.60032591 |
| 77 | MP0001919_abnormal_reproductive_system | 0.57397625 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 0.54324237 |
| 79 | MP0004130_abnormal_muscle_cell | 0.51278465 |
| 80 | MP0004859_abnormal_synaptic_plasticity | 0.50308043 |
| 81 | MP0002095_abnormal_skin_pigmentation | 0.49963436 |
| 82 | MP0003936_abnormal_reproductive_system | 0.48446793 |
| 83 | MP0000627_abnormal_mammary_gland | 0.47766714 |
| 84 | MP0005452_abnormal_adipose_tissue | 0.47749671 |
| 85 | MP0003136_yellow_coat_color | 0.46981704 |
| 86 | MP0008872_abnormal_physiological_respon | 0.44892551 |
| 87 | MP0002557_abnormal_social/conspecific_i | 0.44142678 |
| 88 | MP0010678_abnormal_skin_adnexa | 0.43656490 |
| 89 | MP0002069_abnormal_eating/drinking_beha | 0.42452558 |
| 90 | MP0009643_abnormal_urine_homeostasis | 0.41252128 |
| 91 | MP0001485_abnormal_pinna_reflex | 0.40851086 |
| 92 | MP0001963_abnormal_hearing_physiology | 0.40612621 |
| 93 | MP0005395_other_phenotype | 0.39912165 |
| 94 | MP0000432_abnormal_head_morphology | 0.38867491 |
| 95 | MP0004085_abnormal_heartbeat | 0.38526733 |
| 96 | MP0001756_abnormal_urination | 0.38126058 |
| 97 | MP0006054_spinal_hemorrhage | 0.35931406 |
| 98 | MP0002067_abnormal_sensory_capabilities | 0.32991342 |
| 99 | MP0005390_skeleton_phenotype | 0.32303305 |
| 100 | MP0003953_abnormal_hormone_level | 0.31749416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Volvulus (HP:0002580) | 7.85151956 |
| 2 | Intestinal atresia (HP:0011100) | 7.54559126 |
| 3 | Abnormality of the aortic arch (HP:0012303) | 6.56402113 |
| 4 | Pancreatic islet-cell hyperplasia (HP:0004510) | 6.49571887 |
| 5 | Broad alveolar ridges (HP:0000187) | 6.10296888 |
| 6 | Thickened helices (HP:0000391) | 5.65635340 |
| 7 | Large for gestational age (HP:0001520) | 5.40244449 |
| 8 | Poor head control (HP:0002421) | 5.18355692 |
| 9 | Oligodontia (HP:0000677) | 5.11848625 |
| 10 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.56565496 |
| 11 | Agitation (HP:0000713) | 4.56396772 |
| 12 | Focal motor seizures (HP:0011153) | 4.43001839 |
| 13 | Mesangial abnormality (HP:0001966) | 4.36186046 |
| 14 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.29860455 |
| 15 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.29860455 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 4.23690551 |
| 17 | Abnormality of the ileum (HP:0001549) | 4.04391810 |
| 18 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.02925338 |
| 19 | Large eyes (HP:0001090) | 3.70923185 |
| 20 | Gastrointestinal atresia (HP:0002589) | 3.68786532 |
| 21 | Tented upper lip vermilion (HP:0010804) | 3.52316646 |
| 22 | Tubular atrophy (HP:0000092) | 3.51555331 |
| 23 | Chromsome breakage (HP:0040012) | 3.49031072 |
| 24 | Myositis (HP:0100614) | 3.12546805 |
| 25 | Abnormality of the alveolar ridges (HP:0006477) | 3.10843959 |
| 26 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.10415514 |
| 27 | Hyperpituitarism (HP:0010514) | 3.00966887 |
| 28 | Hypoproteinemia (HP:0003075) | 2.96416327 |
| 29 | Embryonal renal neoplasm (HP:0011794) | 2.92661749 |
| 30 | Hyperthyroidism (HP:0000836) | 2.84397831 |
| 31 | Cerebellar dysplasia (HP:0007033) | 2.81885407 |
| 32 | Orchitis (HP:0100796) | 2.77325012 |
| 33 | Type II lissencephaly (HP:0007260) | 2.75731149 |
| 34 | Pili torti (HP:0003777) | 2.73427130 |
| 35 | Poor speech (HP:0002465) | 2.58006494 |
| 36 | Ectropion (HP:0000656) | 2.56572913 |
| 37 | Neonatal respiratory distress (HP:0002643) | 2.55141726 |
| 38 | Broad-based gait (HP:0002136) | 2.46066951 |
| 39 | Abnormality of nail color (HP:0100643) | 2.45828413 |
| 40 | Optic nerve hypoplasia (HP:0000609) | 2.44941683 |
| 41 | Abnormality of macular pigmentation (HP:0008002) | 2.37558743 |
| 42 | Nonprogressive disorder (HP:0003680) | 2.35790538 |
| 43 | Restlessness (HP:0000711) | 2.33317974 |
| 44 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.31975081 |
| 45 | Hypoplasia of the brainstem (HP:0002365) | 2.31975081 |
| 46 | Long nose (HP:0003189) | 2.31138920 |
| 47 | Goiter (HP:0000853) | 2.30423360 |
| 48 | Focal seizures (HP:0007359) | 2.30243336 |
| 49 | Dialeptic seizures (HP:0011146) | 2.28690714 |
| 50 | Abnormal hair laboratory examination (HP:0003328) | 2.25116371 |
| 51 | Testicular neoplasm (HP:0010788) | 2.24200249 |
| 52 | Striae distensae (HP:0001065) | 2.23983000 |
| 53 | Dysdiadochokinesis (HP:0002075) | 2.23265647 |
| 54 | High anterior hairline (HP:0009890) | 2.23159571 |
| 55 | Lissencephaly (HP:0001339) | 2.22959368 |
| 56 | Abnormality of the vitreous humor (HP:0004327) | 2.22327264 |
| 57 | Increased corneal curvature (HP:0100692) | 2.19677260 |
| 58 | Keratoconus (HP:0000563) | 2.19677260 |
| 59 | Progressive inability to walk (HP:0002505) | 2.19294334 |
| 60 | Cutaneous melanoma (HP:0012056) | 2.18169561 |
| 61 | Central scotoma (HP:0000603) | 2.17073890 |
| 62 | Impulsivity (HP:0100710) | 2.16276316 |
| 63 | Amelogenesis imperfecta (HP:0000705) | 2.16235532 |
| 64 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.10916736 |
| 65 | Entropion (HP:0000621) | 2.10196427 |
| 66 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.08217610 |
| 67 | Generalized tonic-clonic seizures (HP:0002069) | 2.05924245 |
| 68 | Hypercortisolism (HP:0001578) | 2.05813683 |
| 69 | Pigmentary retinal degeneration (HP:0001146) | 2.02272386 |
| 70 | Thyroid-stimulating hormone excess (HP:0002925) | 14.7203314 |
| 71 | Hamartoma (HP:0010566) | 1.99291147 |
| 72 | Lack of skin elasticity (HP:0100679) | 1.98006075 |
| 73 | Congenital stationary night blindness (HP:0007642) | 1.97934657 |
| 74 | Hypohidrosis (HP:0000966) | 1.96363788 |
| 75 | Hydroxyprolinuria (HP:0003080) | 1.95087624 |
| 76 | Abnormality of proline metabolism (HP:0010907) | 1.95087624 |
| 77 | Hypoplasia of the pons (HP:0012110) | 1.93918842 |
| 78 | Poikiloderma (HP:0001029) | 1.91877561 |
| 79 | Scotoma (HP:0000575) | 1.88303842 |
| 80 | Peritonitis (HP:0002586) | 1.88252977 |
| 81 | Pendular nystagmus (HP:0012043) | 1.85948926 |
| 82 | Ileus (HP:0002595) | 1.85005010 |
| 83 | Abnormality of the columella (HP:0009929) | 1.84428545 |
| 84 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.82928841 |
| 85 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.82928841 |
| 86 | Abnormality of glycolipid metabolism (HP:0010969) | 1.82928841 |
| 87 | Muscular dystrophy (HP:0003560) | 1.82171277 |
| 88 | Attenuation of retinal blood vessels (HP:0007843) | 1.79670633 |
| 89 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.77548094 |
| 90 | Abnormality of the pons (HP:0007361) | 1.75698988 |
| 91 | Non-midline cleft lip (HP:0100335) | 1.75563208 |
| 92 | Episodic fever (HP:0001954) | 1.74569718 |
| 93 | Severe visual impairment (HP:0001141) | 1.71698814 |
| 94 | Duplicated collecting system (HP:0000081) | 1.70845513 |
| 95 | Autoimmune hemolytic anemia (HP:0001890) | 1.70508338 |
| 96 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.68964875 |
| 97 | Neoplasm of the lung (HP:0100526) | 1.68869860 |
| 98 | Choroideremia (HP:0001139) | 1.66195493 |
| 99 | Embryonal neoplasm (HP:0002898) | 1.65897916 |
| 100 | 3-Methylglutaconic aciduria (HP:0003535) | 1.65856131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.55310649 |
| 2 | FRK | 5.49692724 |
| 3 | PINK1 | 3.80061922 |
| 4 | IRAK3 | 3.30205993 |
| 5 | ADRBK1 | 2.91597617 |
| 6 | PNCK | 2.17940976 |
| 7 | ADRBK2 | 11.3104450 |
| 8 | TYRO3 | 1.98316818 |
| 9 | DYRK3 | 1.96492426 |
| 10 | IRAK1 | 1.87454266 |
| 11 | ACVR1B | 1.86845806 |
| 12 | PRKCG | 1.86541268 |
| 13 | TGFBR1 | 1.72090749 |
| 14 | RIPK1 | 1.59573910 |
| 15 | PRKCE | 1.59310400 |
| 16 | MAPK11 | 1.43408530 |
| 17 | CLK1 | 1.41814460 |
| 18 | WEE1 | 1.16752601 |
| 19 | BMPR1B | 1.13064326 |
| 20 | PLK2 | 1.07558792 |
| 21 | NEK9 | 1.03214669 |
| 22 | PRKCI | 1.02385711 |
| 23 | GRK1 | 0.99841142 |
| 24 | CAMK1G | 0.87085884 |
| 25 | ERBB2 | 0.80340172 |
| 26 | STK3 | 0.79184997 |
| 27 | CAMK2A | 0.78924445 |
| 28 | MAPKAPK3 | 0.71586376 |
| 29 | STK38L | 0.68856693 |
| 30 | BRSK1 | 0.68707276 |
| 31 | MAPKAPK5 | 0.68108365 |
| 32 | NEK2 | 0.67448153 |
| 33 | MARK3 | 0.62809303 |
| 34 | PTK2B | 0.61278401 |
| 35 | TEC | 0.59468421 |
| 36 | PKN2 | 0.59020990 |
| 37 | GRK5 | 0.55856816 |
| 38 | GRK7 | 0.53568369 |
| 39 | STK38 | 0.53333014 |
| 40 | MKNK1 | 0.50072430 |
| 41 | BRAF | 0.47621632 |
| 42 | MELK | 0.43735649 |
| 43 | PRKCH | 0.41583727 |
| 44 | CAMK1 | 0.41379885 |
| 45 | STK10 | 0.41159310 |
| 46 | DYRK1A | 0.39373864 |
| 47 | SGK1 | 0.39059182 |
| 48 | PRKCB | 0.37940461 |
| 49 | FLT3 | 0.33991689 |
| 50 | MAPK1 | 0.32747415 |
| 51 | CSNK1E | 0.30240789 |
| 52 | PRKCA | 0.29949626 |
| 53 | TAOK3 | 0.28631140 |
| 54 | CSNK1A1L | 0.28440989 |
| 55 | MOS | 0.28313609 |
| 56 | EEF2K | 0.27361645 |
| 57 | MAP2K2 | 0.27163147 |
| 58 | ITK | 0.27059014 |
| 59 | AKT1 | 0.26886096 |
| 60 | MAPK3 | 0.26212937 |
| 61 | EIF2AK3 | 0.25771771 |
| 62 | OXSR1 | 0.23918611 |
| 63 | CAMK4 | 0.23754777 |
| 64 | CSNK2A2 | 0.22959943 |
| 65 | TGFBR2 | 0.22781062 |
| 66 | MST4 | 0.22551585 |
| 67 | ABL1 | 0.22507302 |
| 68 | CDC42BPA | 0.22489183 |
| 69 | RPS6KA3 | 0.22383683 |
| 70 | FER | 0.20211317 |
| 71 | PAK6 | 0.20138042 |
| 72 | MATK | 0.20033693 |
| 73 | STK39 | 0.18489752 |
| 74 | CSNK1A1 | 0.18322761 |
| 75 | MAP3K8 | 0.17569805 |
| 76 | MAP2K1 | 0.17188243 |
| 77 | AURKB | 0.15817850 |
| 78 | CSNK1G3 | 0.14872750 |
| 79 | PRKACG | 0.14329842 |
| 80 | GSK3B | 0.13841261 |
| 81 | ATR | 0.13348010 |
| 82 | TAOK1 | 0.12995813 |
| 83 | PIK3CG | 0.12207287 |
| 84 | PRKACA | 0.12022647 |
| 85 | STK24 | 0.11637729 |
| 86 | SIK2 | 0.11467028 |
| 87 | ATM | 0.10736347 |
| 88 | CSNK1G1 | 0.10385604 |
| 89 | PRKAA1 | 0.10080935 |
| 90 | NME2 | 0.09707936 |
| 91 | PDK1 | 0.08954367 |
| 92 | TNK2 | 0.08397850 |
| 93 | MAPK10 | 0.08230278 |
| 94 | FGFR2 | 0.07388258 |
| 95 | MKNK2 | 0.07337681 |
| 96 | IGF1R | 0.06863053 |
| 97 | TXK | 0.06705274 |
| 98 | CSNK2A1 | 0.06535166 |
| 99 | CDK1 | 0.06414240 |
| 100 | NTRK2 | 0.04871069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.59308906 |
| 2 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 4.51358241 |
| 3 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.56057556 |
| 4 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.34537238 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 3.30407335 |
| 6 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 3.25389849 |
| 7 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 3.12185220 |
| 8 | ABC transporters_Homo sapiens_hsa02010 | 2.94026576 |
| 9 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.60482943 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.51272207 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.44428764 |
| 12 | Phototransduction_Homo sapiens_hsa04744 | 2.38821183 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 2.35667344 |
| 14 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.26778681 |
| 15 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.11018893 |
| 16 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.96882667 |
| 17 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.91428942 |
| 18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.62865230 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.56597918 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.56374916 |
| 21 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.52622644 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.49744327 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47886975 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.46555639 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.43922749 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.39511516 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.37850375 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.30927047 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29662859 |
| 30 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.21404703 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.20856348 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.20650636 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.18682118 |
| 34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.12576065 |
| 35 | Mineral absorption_Homo sapiens_hsa04978 | 1.06467376 |
| 36 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06307171 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.03139050 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.98440323 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.92985420 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.91225699 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90640072 |
| 42 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.84514642 |
| 43 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.83955366 |
| 44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82331051 |
| 45 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78059995 |
| 46 | Basal transcription factors_Homo sapiens_hsa03022 | 0.76832587 |
| 47 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.73170152 |
| 48 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73108723 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.73073331 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70515209 |
| 51 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70234543 |
| 52 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69839294 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 0.69142654 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.68953698 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68559067 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66312481 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63743861 |
| 58 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63364023 |
| 59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62907331 |
| 60 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58418440 |
| 61 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.57261258 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56599565 |
| 63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55737605 |
| 64 | Legionellosis_Homo sapiens_hsa05134 | 0.54278809 |
| 65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53918803 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.51896536 |
| 67 | Homologous recombination_Homo sapiens_hsa03440 | 0.51234690 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.46225799 |
| 69 | Circadian entrainment_Homo sapiens_hsa04713 | 0.44238092 |
| 70 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.43027734 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42759483 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42744561 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38653652 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38520652 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37643307 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.34763350 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33804953 |
| 78 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.32571011 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32446073 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30702399 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.28720687 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27171222 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.26993966 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.25540888 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24847452 |
| 86 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.23219986 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.23065559 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20893070 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20160236 |
| 90 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.17843624 |
| 91 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.16947387 |
| 92 | Insulin secretion_Homo sapiens_hsa04911 | 0.16859870 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.15135825 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.14541323 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.14385668 |
| 96 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.13555908 |
| 97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.13112663 |
| 98 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.12288323 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.11469998 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.10909620 |

